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We conducted a multicomponent, low-cost, home intervention for
children with uncontrolled asthma, the Reducing Ethnic/Racial
Asthma Disparities in Youth (READY) study, to evaluate its ef-
fect on health outcomes and its return on investment. From 2009
through 2014 the study enrolled 289 children aged 2 to 13 years
with uncontrolled asthma and their adult caregivers in Boston and
Springfield, Massachusetts. Community health workers (CHWs)
led in-home asthma management and environmental trigger re-
mediation education over 5 visits  spanning 6 months.  Asthma
health outcomes and indoor environment data were collected via
survey, and health use costs were accessed through Massachusetts
Medicaid  (MassHealth).  Results  showed significant  improve-
ments in asthma control, health care use, and environmental trig-
ger reduction and a positive return on investment (1.34) for parti-
cipants who had 2 or more emergency department visits 1 year pri-
or to the first home visit. The CHW asthma home visiting inter-
vention improved trigger management,  clinical  outcomes,  and
Medicaid cost savings, demonstrating that asthma home visits im-
prove health quality and reduce costs.
Introduction
The effectiveness of home visits by community health workers
(CHWs) to children with asthma in improving health outcomes for
high-risk populations is established in the literature (1). However,
that evidence-based model of care has not been widely adopted by
health care systems, mainly because of limited coverage by health
care payers (2). Although many studies have estimated a positive
return on investment (ROI) for these home visits, few have used
verified cost and use data from participants’ medical claims. This
absence of data is a barrier to widespread payer reimbursement
(3–5). Our study, Reducing Ethnic/Racial Asthma Disparities in
Youth (READY), used insurance claims data to determine the po-
tential cost savings for Massachusetts Medicaid (MassHealth) of
integrating a CHW-led asthma home visiting program into the
medical home model of care. The READY study was approved by
the Massachusetts Department of Public Health (MDPH) Institu-
tional Review Board (Approval # 00000701).
Purpose and Objectives
The READY study evaluated the effect of a CHW-led home inter-
vention on improving outcomes for children with uncontrolled
asthma and the direct and indirect costs associated with the inter-
vention, with a particular focus on Medicaid-enrolled children.
Evaluation Methods
Study population, structure, and sample
The READY study was administered by the Massachusetts De-
partment of Public Health (MDPH) with its clinical partners, Bo-
ston Medical Center and Baystate Medical Center, as study sites,
from September 2009 to April 2014. Both partners serve predom-
inantly low-income Hispanic and non-Hispanic black patient pop-
ulations. To be eligible for the study, a child had to meet at least 1
of 4 criteria: 1) be aged 2 to 13 years and currently a patient of
either study site; 2) have uncontrolled, persistent asthma (6); 3)
have had 1 emergency department visit,  hospitalization, or un-
scheduled office visit for asthma in the past year; or 4) was on a
course of oral steroids in the past year. Recruitment took place
among families with children who were asthma patients at the 2
clinical sites, Boston Medical Center and Baystate Medical Center,
or their affiliated health centers. READY enrolled 289 pairs of
children and their adult caregivers. Two hundred and fifty-four
child–caregiver  pairs  (87.9%)  received  an  initial  visit  from a
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CHW, 170 pairs (58.8%) completed all 5 home visits, and 136
pairs (47.1%) completed a follow-up telephone call 1 year post-
enrollment.
READY  modified  the  evidence-based  protocols  from  the
Seattle–King County Healthy Homes Project (7) for implementa-
tion to integrate CHWs into the medical home team. The READY
protocol consisted of 5 home visits by a CHW over 6 months, plus
a follow-up telephone call at 12 months. CHWs provided asthma
self-management education, environmental trigger remediation
education, and low-cost trigger remediation supplies (eg, HEPA
vacuum cleaners, dust mite covers) (Table 1, Table 2).
The sample size was based on results from the Massachusetts Be-
havioral Risk Factor Surveillance System 2006 Child Call-Back
Survey, a Massachusetts Department of Public Health database, in
which respondents self-reported asthma symptoms in response to
the question, “During the past 30 days, on how many days did you
have  any  symptoms  of  asthma?”  A  sample  size  of  260  was
deemed necessary to detect a minimum difference in the average
number of self-reported asthma symptom days among participants
at  visit  1  compared with visit  5  (post-intervention),  with 80%
power and a type 1 error of 5%.
Data collection and analysis
Two data sources were used for final analyses. Asthma symptoms
and health care use (ie, whether a participant had a hospitalization,
emergency department visit,  or an unscheduled office visit be-
cause of asthma) were collected by caregiver self-report, and en-
vironmental trigger information was collected on the basis of care-
giver self-report and CHW observation at visits 1 and 5. Asthma
control focused on 2 domains: 1) reducing impairment — the fre-
quency and intensity of symptoms and functional limitations cur-
rently or recently experienced by a patient; and 2) reducing risk —
the likelihood of future asthma attacks, progressive decline in lung
function (or, for children, reduced lung growth), or medication
side effects (8). The participants’ levels of asthma control were
classified by using the National Asthma Education Prevention
Program’s Expert Panel Report 3 Full Report 2007: Guidelines for
the Diagnosis and Management of Asthma (8) and were based on
caregiver self-reports. Data used to classify asthma control were
the number of asthma symptom days, the number of nighttime
awakenings, the limitation of normal activity because of asthma,
and the number of times asthma rescue medications were used.
MDPH developed a composite score to quantify indoor environ-
mental asthma triggers. The score was calculated by summing 6
indicators  that  represented the presence of  1  or  more of  the 6
asthma  trigger  measures  (dust,  mold,  pests,  smoke,  pets,  and
chemicals) in the home. Composite scores ranged from 0 to 6,
with a lower score indicating fewer asthma triggers found in the
home. Each trigger indicator score was based on the parental re-
port  of  exposures  to  each asthma trigger  in  the  home and the
CHW’s observations of evidence of triggers. For those study parti-
cipants enrolled in Medicaid, health care use costs were accessed
through MassHealth claims data. All caregivers signed permission
to share information (PSI) forms at enrollment, which allowed
MDPH  to  verify  MassHealth  enrollment  and  access  their
children’s MassHealth claims, if enrolled. Of the 170 children who
completed all 5 home visits, 128 had a signed PSI form, 112 had
matched MassHealth claims during the study period, 99 had 1 year
of continuous Medicaid enrollment before visit 1 (1 year prior to
visit 1 was defined as the control period) and 1 year after visit 5 (1
year after  visit  5 was defined as post  period),  and 70 children
without a third-party payer were included in the analysis. Second-
ary cost analysis was performed among participants with higher
health care use, defined as those with 2 or more emergency depart-
ment claims (n = 22) in the control period. The MassHealth claims
database contains claims for hospitalization, emergency depart-
ment, office visit, and pharmacy. However, pharmacy claims were
incomplete and were not included in the cost analysis.
We used χ2 tests and unpaired t tests to examine differences in cat-
egorical and continuous asthma outcomes between visit 1 and vis-
it 5 from caregiver self-reports. Mann–Whitney U tests were per-
formed to compare changes in medical expenses, and paired t tests
were applied to evaluate differences in health care use during the
control period and post period from MassHealth claims. SAS ver-
sion 9.3 (SAS Institute Inc) was used to perform analyses.
ROI was based on average total preventable asthma costs per par-
ticipant during the control and post periods (the total preventable
asthma costs per participant were total asthma-related hospitaliza-
tion costs and total asthma-related emergency department visit
costs per participant) from MassHealth claims and average pro-
gram costs of the READY intervention per study participant. Pro-
gram costs  were salary and benefits  for  1 full-time equivalent
CHW per clinical site, 0.2 full-time equivalent salary and benefits
for a CHW supervisor per clinical site, and supplies (HEPA vacu-
um cleaners,  mattress  and  pillow  covers,  and  green  cleaning
products). The average participant program costs were based on an
average annual caseload of 40 participants per 1 full-time equival-
ent CHW. ROI was calculated by using this formula:
ROI = (total preventable costs control period – total preventable
costs post period)/present value of program costs
Results
The average age of children who completed visit 1 (n = 254) was
6.2 years; 58.7% were male, 48.0% were non-Hispanic African
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American, 49.2% were Hispanic, and 2.8% were non-Hispanic
white. Most caregivers reported their children had Medicaid as
their health insurer (93.2%).
Results from caregivers’ self-report (n = 254). Intent-to-treat ana-
lysis  using self-reports  showed the average number of  asthma
symptom days decreased 2.97 days (from 5.26 days, standard de-
viation [SD] = 4.07) to 2.29 days [SD = 3.20], P < .001). The pro-
portion of participants with well-controlled asthma showed an ab-
solute increase of 22.9 percentage points (pp) (from 17.7 pp, 95%
confidence interval [CI], 13.02 pp–22.41 pp to 40.6 pp, 95% CI,
33.21 pp–47.97 pp; P = .004). The proportion of participants who
had emergency department visits (absolute decrease of 41.63 pp;
from 64.57 pp [95% CI,  58.69 pp–70.45 pp]  to  22.94 pp,  P <
.001), hospitalizations (absolute decrease 21.09 pp; from 26.38 pp
[95% CI, 20.96 pp–31.80 pp] to 5.29 pp [95% CI, 1.93 pp–8.66
pp], P < .001), or used urgent health services (absolute decrease
37.37 pp; from 80.31 pp [95% CI, 75.43 pp–85.21 pp] to 42.94 pp
[95% CI, 35.50 pp–50.38 pp], P < .001) decreased significantly
between visit 1 and visit 5. The results showed significantly re-
duced environmental trigger exposures, such as dust, mold, pests,
and chemical exposures.
Results  from  participants’  MassHealth  claims  (n  =  70).
MassHealth claims (Table 3) showed that the average number of
asthma-related emergency department visits per year decreased
46% (from 0.93 to 0.50, P = .004) between the control period and
post period. When analyses were restricted to participants with 2
or more emergency department visits during the control period,
the average number of asthma related emergency department vis-
its decreased 63%, from 2.59 visits to 0.95 visits, P < .001.
The ROI was 0.49 for participants who completed all 5 visits (n =
70) and 1.34 for the higher-use participants (n = 22).
Implications for Public Health
The READY study demonstrated that a CHW asthma home visit-
ing intervention not only improves health outcomes and reduces
indoor asthma triggers, but also reduces Medicaid costs for pediat-
ric patients. Few studies evaluating the efficacy and cost-savings
for payers of pediatric asthma home visiting have used participant
medical claims and have instead relied on nonpayment measures
(9). READY compared participants’ MassHealth claims from the
control period and post period of the intervention and confirmed
significant reductions in asthma-related emergency department
visits and associated costs, both for all participants and for higher-
use participants. Cost reductions were also observed for asthma
hospitalization but were not significant. READY further demon-
strated a positive ROI for higher-use participants, a finding which
would be achieved for the entire participant sample with addition-
al years of follow-up, as described in other studies (10). Actual
health care savings may also be underestimated because many
children with asthma have family members with asthma who were
not tracked, but also may have benefitted from the intervention
(11).
Our study has several limitations. First, the health outcome analys-
is was based on caregivers’ self-report, which may introduce bias.
Second, the sample size of MassHealth claims analyzed was small
because of continuous enrollment and the requirement for signed
PSI forms. A planned analysis using a comparison group drawn
from  MassHealth  claims  could  not  be  completed  because
MassHealth claims do not contain race/ethnicity fields. Lastly,
pharmacy claims were incomplete and could not be included.
The READY study showed that CHW-led asthma home visiting
programs can produce short-term Medicaid cost savings and more
appropriate asthma care use. For example, the noted 63% reduc-
tion in emergency department visits by those with 2 or more emer-
gency department visits in the control period demonstrated that
these participants avoided, on average, more than 1 emergency de-
partment visit in the post intervention period. Because it was not
possible to determine the specific intervention components driv-
ing these use reductions, this result underscores the importance of
multitrigger multicomponent asthma home visits led by CHWs.
Because many states have moved from fee-for-service payment
structures toward value-based payments, the results of READY of-
fer health care systems an opportunity for meeting the triple aim of
improving health,  improving quality,  and reducing costs  (12).
READY advances the literature by demonstrating cost savings and
positive ROI using participants’ Medicaid claims data for CHW-
led asthma home visiting interventions integrated into medical
home teams.  The ability of  asthma home visiting programs to
achieve 2 of the components of the triple aim (improved health
outcomes and improved quality of care) has been previously estab-
lished (13); now READY has demonstrated that this intervention
can also lead to better value.
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Tables
Table 1. Intervention Timeline, Reducing Ethnic/Racial Asthma Disparities in Youth (READY) Study, 2009–2014
Intervention activity
Visit Numbera
1 2 3 4 5
Month of visitb 0 0.5 1 2 6
Activity
General
Project overview X X — — —
Set asthma and home priorities and make plan — X — — —
Revisit family priorities — — X X X
Environmental assessment/education
Home environmental walk-through — X — — —
Pest education, develop plan — — X — —
Dust mite education, develop plan — X — — —
Pets education, develop plan — X — — —
Mold education, develop plan — X — — —
Dust control education, develop plan — — — X —
Tobacco education, develop plan — — X (X) —
Reassessment of environmental plans — — X X (X)
Social assessment/education
Urgent needs assessment, link with services X X — — —
Revisit needs — X (X) (X) (X)
Asthma assessment/education
Asthma basics X (X) — — —
Asthma management education — — X X X
Asthma trigger identification and avoidance — X X X —
Asthma care understanding and assessments of barriers to optimal asthma control X X X X X
Abbreviation: —, no activity at a visit; X, activity occurred at a visit; (X), activity may have occurred at a visit (at community health worker’s discretion).
a Five visits were made over a 6-month period.
b Refers to the month of the 6-month study. Some visits were conducted mid month (ie, month 0.5).
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Table 2. Evaluation Timeline, Reducing Ethnic/Racial Asthma Disparities in Youth (READY) Study, 2009–2014
Data Collection and Evaluation
Visit Numbera
1 2 3 4 5
Month of Visitb 0 0.5 1 2 4–6
Consent form (READY and MassHealth permission to share information) X — — — —
Home environmental checklist (from Seattle Home Study [7])  — X — — X
Encounter form (to document CHW actions in home) X X X X X
Environmental action plan — X X X X
Asthma 2-week recall symptom checklist (from Seattle Home Study [7]) X X X X X
Baseline survey 1 (asthma data including the Pediatric Asthma Caregiver Quality of Life [14]) X — — — X
Baseline survey 2 (parental expectations, asthma triggers) — X — — X
Abbreviation: —, no activity at a visit; X, activity occurred at a visit; (X), activity may have occurred at a visit (at community health worker’s discretion).
a Five visits were made over a 6-month period.
b Refers to the month of the 6-month study. Some visits were conducted mid month (ie, month 0.5).
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Table 3. Insurance Claims for Participants (N = 70) Covered by MassHealth (Medicaid) Related to Asthma, Reducing Racial/Ethnic Asthma Disparities in Youth
(READY) Study, Massachusetts, 2009–2014
Variable
Control Perioda Post Periodb
P ValuecMean (Standard Deviation) Mean (Standard Deviation)
Participants who completed all 5 visits (n = 70)
Average cost per person, $
Hospitalization 1,059.22 (3,199.62) 506.20 (1,948.86) .11
Emergency department visits 534.73 (809.61) 223.41 (473.77) .001
Office visits 473.77 (618.94) 406.17 (537.90) .32
Health care events, no.
Hospitalization 0.21 (0.66) 0.10 (0.39) .11
Emergency department visits 0.93 (1.15) 0.50 (0.86) .004
Office visits 3.19 (3.28) 2.96 (3.09) .69
Participants who completed all 5 visits and had 2 or more emergency department visits during control period (n = 22)
Average cost per person, $
Hospitalization 2,543.76 (4,372.83) 1,243.14 (4,378.39) .23
Emergency department 1,512.87 (828.25) 454.39 (1,206.34) .009
Office 730.22 (868.92) 739.91 (773.25) .52
Health care events, no.
Hospitalization 0.64 (1.09) 0.32 (0.78) .13
Emergency department visit 2.59 (1.01) 0.95 (2.21) <.001
Office visit 4.50 (4.61) 4.86 (4.14) .65
a Control period was defined as 1 year prior to visit 1.
b Post period was defined as 1 year after visit 5.
c P < .05 indicates significance.
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